Activating Transcription Factor 5 (ATF5) (N-Term) Peptide
ATF5
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all ATF5 products
- ATF5 (Activating Transcription Factor 5 (ATF5))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- MASLLKKELE QMEDFFLDAP PLPPPSPPPL PPPPLPPAPS LPLSLPSFDL
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-ATF5 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ATF5 (Activating Transcription Factor 5 (ATF5))
- Background
-
Overexpression of the bZIP protein ATF5, a transcriptional activator, stimulates asparagine synthetase promoter/reporter gene transcription via the nutrient-sensing response unit. ATF5 is also a new interacting partner of cyclin D3.
Alias Symbols: ATFX, HMFN0395
Protein Size: 282 - Molecular Weight
- 31 kDa
- Gene ID
- 22809
- NCBI Accession
- NM_012068, NP_036200
- UniProt
- Q9Y2D1
-
You are here:
